Informatie:
Fout:
ID
30893
Beschrijving
Study part: Logs and Repeats (Logs/Rpts). A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Trefwoorden
Versies (1)
- 02-07-18 02-07-18 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
2 juli 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Logs and Repeats (Logs/Rpts) Pazopanib Macular Degeneration MD1103367
Logs and Repeats (Logs/Rpts)
- StudyEvent: ODM
Similar models
Logs and Repeats (Logs/Rpts)
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Date of visit
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
Item Group
ADVERSE EVENT/CONCOMITANT MEDICATION/REPEAT ASSESSMENT CHECK QUESTIONS
C0877248 (UMLS CUI-1)
C2347852 (UMLS CUI-3)
C0681799 (UMLS CUI-5)
C2347852 (UMLS CUI-3)
C0681799 (UMLS CUI-5)
Item
Were any concomitant medications taken by the subject during the study?
text
C2347852 (UMLS CUI [1])
CL Item
Yes (Y)
CL Item
No (N)
Item
Did the subject experience any adverse events during the study?
text
C0877248 (UMLS CUI [1])
CL Item
Yes (Y)
CL Item
No (N)
Item
Were any repeat haematology or clinical chemistry samples taken?
text
C0474523 (UMLS CUI [1])
C0008000 (UMLS CUI [2])
C0008000 (UMLS CUI [2])
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Yes (Y)
CL Item
No (N)
Geen commentaren